At Bayer, one of the largest pharmaceutical companies in the world, gaining a deep understanding of biological systems is paramount for the discovery of new therapeutics. This is inspiring the adoption of technologies that can accelerate and automate discovery, spanning all of the components of their data infrastructure, starting with the database.
The challenges posed within the data and discovery process are not unique to Bayer: